• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Healthcare

Volume Slows Ahead of Christmas Holiday

Breadth is slightly negative as markets ease into 3-day weekend.
By JAMES "REV SHARK" DEPORRE
Dec 22, 2017 | 02:02 PM EST
Stocks quotes in this article: MARK, AIMT, TEP, TEGP, FB, AMZN, AAPL, NFLX, GOOGL

Volume is slowing and the indices are drifting as market players head out to enjoy the holiday weekend. Breadth is running slightly negative with around 3,100 gainers to 3,600 losers. New 12-month highs are down to around 200.  FAANG names -- Facebook (FB) , Amazon (AMZN) , Apple (AAPL) , Netflix (NFLX) and Alphabet (GOOGL) --  are slightly weak and with the crypto/blockchain action there aren't many pockets of momentum right now.

There has been much hoopla over the sharp drop in bitcoin today which has prompted some dramatic headlines, but this has always been a highly volatile group and that works in both directions.  The crypto/blockchain frenzy is far from over which means we should have some good opportunities. We just have to wait for them to set up. It is actually a good thing that the market is starting to distinguish between the junk and the stocks that have substance.  If you listen to some pundits you would be led to believe they are all blatant frauds.

We'll try to pick up the better blockchain names in the weeks ahead. They have been a very nice distraction lately but I want to focus on some other names that are working well. My Stock of the Week Remark Media (MARK) is acting well today and is at a new closing high currently.  This chart setup looks attractive for sustained momentum.

One biotech that is developing quite well is Aimmune Therapeutics (AIMT) .  It received a target price of $84 from Baird this week and is working on a breakout attempt over 39.

One group that may be of interest due to end of the year changes is the MLP oil plays.  They have likely seen tax selling and are now bouncing back. Tallgrass ( (TEP) and (TEGP) ) are on my radar.

I am heading out to take care of some Christmas preparations and I want to wish everyone a Merry Christmas and Happy Holidays.   Hopefully we will have some fun next week as we wrap up the weeks.

As a Christmas gift I'd like to offer you a free copy of a short book I have written called 'RevShark's Essential Guide to Market Success.' 

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark had no positions in any stocks mentioned.


At the time of publication, Action Alerts PLUS, which Jim Cramer co-manages as a charitable trust, was long GOOGL, FB and AAPL.

TAGS: Investing | U.S. Equity | Healthcare | Cryptocurrency | Technology | Bitcoin | Stocks

More from Healthcare

Moderna's Chart Messages Are Frustrating the Bulls

Bruce Kamich
Sep 19, 2023 9:20 AM EDT

The technical indicators suggest that traders should wait until a bottom pattern plays out in the shares of the vaccine maker.

This Biotech Stock Pick Is Just Starting to Make Beautiful Music

Bret Jensen
Sep 15, 2023 9:00 AM EDT

Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.

UnitedHealth Shares Are Not Looking All That Healthy

Bruce Kamich
Sep 14, 2023 11:05 AM EDT

Let's take the temperature of this important Dow component.

Moderna: Is It Time to Take a Shot?

Bruce Kamich
Sep 13, 2023 12:52 PM EDT

Let's review the trends, charts and indicators.

For Potential Alkermes Buyers, There's a Key Price Level to Watch

Bruce Kamich
Sep 13, 2023 10:50 AM EDT

The key question now is whether the biopharmaceutical stock can break out to the upside.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:20 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Trading in Multiple Time Frames
  • 10:24 AM EDT BRUCE KAMICH

    This Could Get Messy

    A number of key stocks are getting close to import...
  • 01:41 PM EDT CHRIS VERSACE

    Latest AAP Podcast With Helene Meisler!

    Listen in as the Action Alerts PLUS podcast talks ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login